Journal of clinical pharmacology

Keyphrases

Publications

2023

Tetsuro Ogawa, Sachiko Mita, Harisha Atluri, Yuki Iwaki
Population Pharmacokinetic and Exposure-Safety Analyses of Ibrutinib for the Treatment of Chronic Graft-Versus-Host Disease. Journal of clinical pharmacology (2023)
Gerald Yakatan
In Memoriam. Journal of clinical pharmacology (2023)
Elijah Weber, Islam Younis, Cara Nelson, Dora Ding, Ann Qin, Deqing Xiao, Timothy R Watkins, Ahmed A Othman
Effect of Renal Impairment on the Pharmacokinetics of Firsocostat, an Acetyl-CoA Carboxylase (ACC) Inhibitor, and Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist. Journal of clinical pharmacology (2023)
Xuejun Chen, Zhiyin Xun, Brad Yuska, Ryan McGee, Swamy Yeleswaram
Itacitinib Population Pharmacokinetics and Exposure-Response in Patients With Acute Graft-Versus-Host Disease. Journal of clinical pharmacology (2023)
Ana Rouselle Reyes-Ramos, Ivan Arni Caballero Preclaro, Michelle Marie S Castillo, Sarah Elizabeth S Basco
Stevens-Johnson Syndrome in an HLA-B*38:16 and B*58:17 Positive Adult FILIPINO Male Associated With Allopurinol: A Case Report. Journal of clinical pharmacology (2023)
Sören Büsker, Alan Wayne Jones, Robert G Hahn, Max Taubert, Ulrich Klotz, Matthias Schwab, Uwe Fuhr
Population Pharmacokinetics As A Tool To Re-Evaluate The Complex Disposition of Ethanol In The Fed And Fasted State. Journal of clinical pharmacology (2023)
Ana Rouselle Reyes-Ramos, Ivan Arni Caballero Preclaro, Michelle Marie S Castillo, Sarah Elizabeth S Basco
Stevens-Johnson Syndrome in an Adult Filipino Male Positive for HLA-B*38:16 and B*58:17, Associated With Allopurinol: A Case Report. Journal of clinical pharmacology (2023)
Priscila Akemi Yamamoto, Rodrigo Cristofoletti, Valvanera Vozmediano, Cristiane Masetto de Gaitani, Rodrigo Moreira da Silva, Rafael Kemp, Ajith Kumar Sankarankutty, Wilson Salgado Junior, Jose Sebastião Dos Santos, Natalia Valadares de Moraes
Effect of Roux-En-Y Gastric Bypass In The Pharmacokinetics of (R)-Carvedilol and (S)-Carvedilol. Journal of clinical pharmacology (2023)
Jong Bong Lee, Wangda Zhou, Zhenhua Xu, Joseph A Hedrick, Jocelyn H Leu
Population Pharmacokinetics and Exposure-Response Modeling Analyses of Golimumab in Children and Young Adults with Recently Diagnosed Type 1 Diabetes (T1D). Journal of clinical pharmacology (2023)
Li Zhang, Lei Zhang, Ping Li, Chenwei Liu, Qiwen Zheng, Yan Wang
Low Early Antifactor Xa Target Achievement Rate of Low-Molecular-Weight Heparin for Treating Venous Thromboembolism in Patients in Intensive Care. Journal of clinical pharmacology (2023)
Sören Büsker, Alan Wayne Jones, Robert G Hahn, Max Taubert, Ulrich Klotz, Matthias Schwab, Uwe Fuhr
Population Pharmacokinetics as a Tool to Reevaluate the Complex Disposition of Ethanol in the Fed and Fasted States. Journal of clinical pharmacology (2023)
Thomas N Kakuda, Atef Halabi, Gernot Klein, Madhu Sanga, Carine Guinard-Azadian, Monika Kowalik, Katja Nedoschinsky, Julius Nangosyah, Emmanuel Njumbe Ediage, Vera Hillewaert, Peter Verboven, Ivo Goris, Jan Snoeys, Martyn Palmer, Michael Biermer
Pharmacokinetics of JNJ-73763989 and JNJ-56136379 (Bersacapavir) in Participants With Moderate Hepatic Impairment. Journal of clinical pharmacology (2023)
Thomas N Kakuda, Atef Halabi, Gernot Klein, Madhu Sanga, Carine Guinard-Azadian, Monika Kowalik, Katja Nedoschinsky, Julius Nangosyah, Emmanuel Njumbe Ediage, Vera Hillewaert, Peter Verboven, Ivo Goris, Jan Snoeys, Martyn Palmer, Michael Biermer
Pharmacokinetics of Jnj-73763989 And Jnj-56136379 (Bersacapavir) In Participants With Moderate Hepatic Impairment. Journal of clinical pharmacology (2023)
David Rodrigues, Mark Niosi, Heather Eng, Christopher Healy, Sarah Lazzaro, Qingyi Yang, Matthew A Cerny
Attempting to Unmask the Inhibition of Sulfotransferase 1E1 in 17α-Ethinyl Estradiol Drug Interactions. Journal of clinical pharmacology (2023)
Craig B H Surman, Daniel M Walsh
Do ADHD Treatments Improve Executive Behavior Beyond Core ADHD Symptoms in Adults? Evidence From Systematic Analysis of Clinical Trials. Journal of clinical pharmacology (2023)
Shinichiro Shirae, Yuri Tsuruya, Tomohito Kozaki, Junnosuke Mizuhata, Atsushi Ose
Population Pharmacokinetics, Exposure-Safety, and Probability of Target Attainment Analyses for Isavuconazole in Japanese Patients With Deep-Seated Mycoses. Journal of clinical pharmacology (2023)
Deying Xie, Fei Liu, Yunxia Zuo
Effectiveness of Sufentanil-based Patient-controlled Analgesia Regimen in Children and Incidence of Adverse Events Following Major Congenital Structure Repairs. Journal of clinical pharmacology (2023)
Craig B H Surman, Daniel M Walsh
Do ADHD Treatments Improve Executive Behavior Beyond Core ADHD Symptoms in Adults? Evidence From Systematic Analysis of Clinical Trials. Journal of clinical pharmacology (2023)
Tetsuro Ogawa, Sachiko Mita, Harisha Atluri, Yuki Iwaki
Population pharmacokinetic and exposure-safety analyses of ibrutinib for the treatment of chronic graft-versus-host disease. Journal of clinical pharmacology (2023)
Einstein Francisco Camargos, Otávio Toledo Nóbrega
Revisiting Old Drugs Owing to Glymphatic System: A Step Towards Unlocking The Role of Hypnotics In Brain Health. Journal of clinical pharmacology (2023)
Tomohiro Aigami, Tomoyuki Ishigo, Ryo Takada, Toshiyuki Yano, Masayuki Koyama, Satoshi Katano, Satoshi Fujii, Masahide Fukudo
Comparison OF The Treatment Persistence Among Four Direct Oral Anticoagulants In Patients With Non-Valvular Atrial Fibrillation: A 5-Year Retrospective Cohort Study. Journal of clinical pharmacology (2023)
Melody White, C Michael White
The Impact of Sedative Hypnotic Drugs on Hallucinated Sexual Assault or Sexual Fantasies Involving Health Professionals: A Systematic Review. Journal of clinical pharmacology (2023)
Tomohiro Aigami, Tomoyuki Ishigo, Ryo Takada, Toshiyuki Yano, Masayuki Koyama, Satoshi Katano, Satoshi Fujii, Masahide Fukudo
Comparison of the Treatment Persistence Among 4 Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A 5-Year Retrospective Cohort Study. Journal of clinical pharmacology (2023)
Elijah Weber, Islam R Younis, Cara Nelson, Dora Ding, Ann Qin, Deqing Xiao, Timothy R Watkins, Ahmed A Othman
Effect of Renal Impairment on the Pharmacokinetics of Firsocostat, an Acetyl-Coenzyme A Carboxylase Inhibitor, and Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist. Journal of clinical pharmacology (2023)
Li Zhang, Ping Li, Chenwei Liu, Qiwen Zheng, Yan Wang
Low early anti-factor Xa target achievement rate of low molecular weight heparin for treating venous thromboembolism in intensive care unit patients. Journal of clinical pharmacology (2023)
Xin-Fang Hou, Xin-Xin Zhang, Shuai Li, Chen Wu, Xiao-Bing Chen
A Retrospective Cohort Study Examining The Effects of Anti-Pd-1 Antibody in Combination with Apatinib in Patients Previously Treated for Her2-Negative Advanced Gastric/Gastroesophageal Junction Cancer. Journal of clinical pharmacology (2023)
Gaoqi Xu, Dihong Yang, Qi Shu, Junfeng Zhu, Haiying Ding, Wenxiu Xin, Like Zhong, Liqin Zhu, Luo Fang
Population pharmacokinetics of anlotinib, a multiple receptor tyrosine kinase inhibitor, in chinese patients with malignant tumors. Journal of clinical pharmacology (2023)
Xiaoxing Wang, Vivek Purohit, Martin E Dowty, David Rodrigues, Lina Luo, Sumathy Mathialagan, William Carey, Anna Plotka, Hindu Kalluru, O'Gorman Melissa, Julia Kaplan, Yeamin Huh, Manoli Vourvahis, Robert M Wolk
Evaluation of the Impact of Ritlecitinib on Organic Cation Transporters Using Sumatriptan and Biomarkers as Probes. Journal of clinical pharmacology (2023)
Hui Wu, Shaobin Jia
A Comparative Study on Ticagrelor and Clopidogrel in Patients With Acute Coronary Syndrome Treated With Primary Percutaneous Coronary Intervention. Journal of clinical pharmacology (2023)
Shinichiro Shirae, Yuri Tsuruya, Tomohito Kozaki, Junnosuke Mizuhata, Atsushi Ose
Population Pharmacokinetics, Exposure-Safety, And Probability Of Target Attainment Analyses For Isavuconazole In Japanese Patients With Deep-Seated Mycoses. Journal of clinical pharmacology (2023)
Yasuyuki Okumura, Takeshi Kimura, Shoichiro Inokuchi, Masahiro Okamoto, Toshio Takano, Masumi Miyake, Yuji Kumagai
Real-World Hepatic Safety of Oral Acetaminophen versus Loxoprofen/Celecoxib: Using a Nationwide Electronic Medical Record Database. Journal of clinical pharmacology (2023)
Lin Cheng, Zaiming Liang, Xi You, Changsheng Jia, Zhirui Liu, Fengjun Sun
The Role of the Mesencephalic Astrocyte-Derived Neurotrophic Factor in Patients in Intensive Care Units Receiving Voriconazole Therapy. Journal of clinical pharmacology (2023)
Yanbin Zeng, Xiaohui Guo, Fengjiao Xiao, Haixia Zhang
Cardiovascular and Cerebrovascular Safety of Ranibizumab, Bevacizumab, and Aflibercept in Ocular Diseases: an Analysis of the FDA Adverse Event Reporting System database (FAERS). Journal of clinical pharmacology (2023)
Zaid Temrikar, Elena Muensterman, Benjamin Engelhardt, Mohamed-Eslam F Mohamed
Use of Clinical Trial Simulations to Compare the Performance of Different Approaches for Population Analyses of Pediatric Pharmacokinetic Data. Journal of clinical pharmacology (2023)
Cody J Peer, Keith T Schmidt, Oluwatobi Arisa, William J Richardson, Koosha Paydary, Daniel A Goldstein, James L Gulley, William D Figg, Mark J Ratain
In Silico Re-Optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure-Response Simulation. Journal of clinical pharmacology (2023)
Lin Cheng, Zaiming Liang, Xi You, Changsheng Jia, Zhirui Liu, Fengjun Sun
The Role of the Mesencephalic Astrocyte-Derived Neurotrophic Factor in Intensive Care Unit Patients Receiving Voriconazole Therapy. Journal of clinical pharmacology (2023)
Atsushi Kitamura, Takuya Yumizaki, Tomoe Kondo, Hisakuni Sekino, Hiroyoshi Kakuyama
Pharmacokinetics and Safety of Imeglimin in Japanese Patients with Impaired Renal Function. Journal of clinical pharmacology (2023)
Wanhong Wu, Rongfang Lin, Meng Ke, Lingling Ye, Cuihong Lin
Physiologically based pharmacokinetic modeling characterizes the drug-drug interaction between saxagliptin and rifampicin in patients with renal impairment. Journal of clinical pharmacology (2023)
Cody J Peer, Keith T Schmidt, Oluwatobi Arisa, William J Richardson, Koosha Paydary, Daniel A Goldstein, James L Gulley, William D Figg, Mark J Ratain
In Silico Re-Optimization of Atezolizumab Dosing using Population Pharmacokinetic and Exposure-Response Simulation. Journal of clinical pharmacology (2023)
Emma M Tillman, Miley G Nikirk, Jeanne Chen, Todd C Skaar, Tyler Shugg, Judith P Maddatu, Asif A Sharfuddin, Michael T Eadon
Implementation of Clinical CYP3A Genotyping for Tacrolimus Dosing in A Large Kidney Transplant Program. Journal of clinical pharmacology (2023)
Deying Xie, Fei Liu, Yunxia Zuo
Effectiveness of Sufentanil-Based Patient-Controlled Analgesia Regimen in Children and Incidence of Adverse Events Following Major Congenital Structure Repairs. Journal of clinical pharmacology (2023)
Michael Hwang, Chunling Fan, Mun Sang Yue, Diansong Zhou, Carine Paturel, Pascale Andre, Lin-Yang Cheng, Patrick Mitchell, Panagiotis Kourtesis, Dario Ruscica, Mayukh Das, Nassim Morsli, Song Ren, Megan Gibbs, Alex Phipps, Xuyang Song
Population Pharmacokinetics of Monalizumab in Patients with Advanced Solid Tumors. Journal of clinical pharmacology (2023)
Robert Krysiak, Karolina Kowalcze, Bogusław Okopień
Autoimmune Thyroiditis Attenuates Cardiometabolic Effects of Cabergoline in Young Women With Hyperprolactinemia. Journal of clinical pharmacology (2023)
Shimon Suzuki, Shungo Imai, Satoru Mitsuboshi, Hayato Kizaki, Masayuki Hashiguchi, Satoko Hori
Detection of vaccine adverse events before package insert revisions using a Japanese spontaneous reporting system. Journal of clinical pharmacology (2023)
Martina D Sahre, Daphne Guinn, Anuradha Ramamoorthy, Insook Kim, Xinyuan Zhang, Ruby Mehta, Shirley Seo, Mehul Mehta, Jogarao V S Gobburu, Rajanikanth Madabushi
Assessing Pharmacokinetics in Liver Disease: Challenges and Future Considerations for Classification of Hepatic Dysfunction and use of in Silico Methods. Journal of clinical pharmacology (2023)
Sarah Ridge, Daphne Guinn, Elimika Pfuma Fletcher, Issam Zineh, Rajanikanth Madabushi, Anuradha Ramamoorthy
US FDA Postmarketing Requirements and Commitments: A Systematic Assessment of Clinical Pharmacology Studies and Their Impact on US FDA Prescribing Information. Journal of clinical pharmacology (2023)
Sarah Ridge, Daphne Guinn, Elimika Pfuma Fletcher, Issam Zineh, Rajanikanth Madabushi, Anuradha Ramamoorthy
US FDA Postmarketing Requirements and Commitments: A Systematic Assessment of Clinical Pharmacology Studies and Their Impact on US Prescribing Information. Journal of clinical pharmacology (2023)
Xuejun Chen, Zhiyin Xun, Brad Yuska, Ryan McGee, Swamy Yeleswaram
Itacitinib Population Pharmacokinetics and Exposures/Response in Patients With Acute Graft-Versus-Host Disease. Journal of clinical pharmacology (2023)

volume 63, number 4, 2023

Bojan Lalovic, Ishani Savant Landry, Margaret Moline, Larisa Reyderman, Ziad Hussein
Exposure-Response Analyses of Polysomnography and Subjective Sleep Efficacy End Points From the Phase 3 Trials of Lemborexant, a Dual Orexin Receptor Antagonist for the Treatment of Insomnia. Journal of clinical pharmacology 63 (4) (2023)
Bojan Lalovic, Ishani Savant Landry, Margaret Moline, Larisa Reyderman, Ziad Hussein
Exposure-Response Analyses of Polysomnography and Subjective Sleep Efficacy End Points From the Phase 3 Trials of Lemborexant, a Dual Orexin Receptor Antagonist for the Treatment of Insomnia. Journal of clinical pharmacology 63 (4) (2023)